Structure-Activity Relationship of 4,6-Disubstituted Pyrimidines as EGFR and VEGFR-2 Tyrosine Kinase Inhibitors

被引：2
作者：
Song, Jiho [1 ]
Lee, Jung Wook [1 ]
Chung, Shin Hyuck [1 ]
Wenas, Michelle A. [1 ]
Min, Kyung Hoon [1 ]
机构：
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
来源：
BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2017年 / 38卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
EGFR; VEGFR-2; Tyrosine kinase inhibitors; Pyrimidine; GROWTH-FACTOR RECEPTOR; BEVACIZUMAB; ERLOTINIB; CANCER; RESISTANCE; THERAPY; CELL;
D O I：
10.1002/bkcs.11278
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：1255 / 1256
页数：2
相关论文
共 50 条
  • [21] Structure-Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017-Present)
    Sandor, Alexandru
    Ionut, Ioana
    Marc, Gabriel
    Oniga, Ilioara
    Eniu, Dan
    Oniga, Ovidiu
    PHARMACEUTICALS, 2023, 16 (04)
  • [22] New 2-oxoindole derivatives as multiple PDGFRα/ß and VEGFR-2 tyrosine kinase inhibitors
    Ezelarab, Hend A. A.
    El-Hafeez, Amer Ali Abd
    Ali, Taha F. S.
    Sayed, Ahmed M.
    Hassan, Heba A.
    Beshr, Eman A. M.
    Abbas, Samar H.
    BIOORGANIC CHEMISTRY, 2024, 145
  • [23] Quantitative structure-activity relationship study of novel, potent, orally active, selective VEGFR-2 and PDGFRα tyrosine kinase inhibitors:: Derivatives of N-Phenly-N′-{4-(4-quinolyloxy)phenyl)urea as antitumor agents
    Sharma, B. K.
    Sharma, S. K.
    Singh, P.
    Sharma, Susheela
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2008, 23 (02) : 168 - 173
  • [24] Optimization of 4,6-Disubstituted Pyrido[3,2-d]pyrimidines as Dual MNK/PIM Inhibitors to Inhibit Leukemia Cell Growth
    Han, Yu
    Zhang, Huimin
    Wang, Shuxiang
    Li, Bo
    Xing, Kun
    Shi, Yuntao
    Cao, Hongxue
    Zhang, Jian
    Tong, Tong
    Zang, Jie
    Guan, Lihong
    Gao, Xiaoxiao
    Wang, Yuetong
    Liu, Dan
    Huang, Min
    Jing, Yongkui
    Zhao, Linxiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (18) : 13719 - 13735
  • [25] An appraisal of anticancer activity with structure-activity relationship of quinazoline and quinazolinone analogues through EGFR and VEGFR inhibition: A review
    Haider, Kashif
    Das, Subham
    Joseph, Alex
    Yar, M. Shahar
    DRUG DEVELOPMENT RESEARCH, 2022, 83 (04) : 859 - 890
  • [26] Novel 5-anilinoquinazoline-8-nitro derivatives as inhibitors of VEGFR-2 tyrosine kinase: synthesis, biological evaluation and molecular docking
    Xi, Liang
    Zhang, Jian-Qiang
    Liu, Zhi-Cheng
    Zhang, Ji-Hong
    Yan, Ju-Fang
    Jin, Yi
    Lin, Jun
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2013, 11 (26) : 4367 - 4378
  • [27] Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile
    Mghwary, Aml E. -S.
    Gedawy, Ehab M.
    Kamal, Aliaa M.
    Abuel-Maaty, Suzan M.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 838 - 852
  • [28] Identification of new pyrrolo [2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling
    Adel, Mai
    Serya, Rabah A. T.
    Lasheen, Deena S.
    Abouzid, Khaled A. M.
    BIOORGANIC CHEMISTRY, 2018, 81 : 612 - 629
  • [29] Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review
    Metwally, Kamel
    Abo-Dya, Nader E.
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (36) : 5918 - 5936
  • [30] Design, synthesis and anticancer activity of furochromone and benzofuran derivatives targeting VEGFR-2 tyrosine kinase
    Abdelhafez, Omaima M.
    Ali, Hamed I.
    Amin, Kamelia M.
    Abdalla, Mohamed M.
    Ahmed, Eman Y.
    RSC ADVANCES, 2015, 5 (32) : 25312 - 25324
12345